High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.Mark W. Brunvand, CD Buckner, Jack W. Singer et al.|PubMed|1996Cited by 645
Long‐term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non‐Hodgkin lymphomaPeter Martin, John P. Leonard, Jonathan W. Friedberg et al.|British Journal of Haematology|2017Cited by 33
Long-Term Outcomes, Secondary Malignancies, and Stem Cell Collection Following Bendamustine in Patients with Previously Treated Indolent Non-Hodgkin LymphomaPeter Martin, John P. Leonard, Zhengming Chen et al.|Blood|2015Cited by 0